市场调查报告书
商品编码
1384962
排卵检测套组的全球市场规模、份额和行业趋势分析报告:2023-2030 年按产品、通路和地区分類的展望和预测Global Ovulation Testing Kits Market Size, Share & Industry Trends Analysis Report By Product (Urine Ovulation Test, Digital Ovulation Test, and Saliva Ovulation Test), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030 |
预计到 2030 年,排卵检测套组市场规模将达到 37 亿美元,预测期内CAGR为 6.4%。 2022年市场规模为506,912,700辆,成长4.8%(2019-2022年)。
大流行的最大影响之一是对家庭医疗产品(包括排卵检测套组)的需求激增。由于封锁和限制,许多人试图限制前往医疗机构、诊所和药房。因此,人们越来越偏好家庭医疗保健解决方案,包括排卵检测套组。因此,排卵检测套组市场的销售量大幅成长。同时,对于那些积极尝试怀孕的人来说,随着大流行期间最大限度地提高成功机会的重要性增加,排卵检测套组的使用也有所增加。
然而,不准确的结果,例如误报(在未发生时显示排卵)和漏报(在发生 LH突波时未能检测到)可能会导致使用者困惑和沮丧。这种不准确的情况可能会影响计划生育配合措施并引发消费者的怀疑。排卵检测套组的品质和一致性在品牌内部和品牌之间可能有所不同。不一致的结果可能会损害这些产品的声誉并阻碍重复购买。使用者可能并不总是正确遵循说明,这可能会导致结果不准确。製造商必须透过提供清晰详细的说明来解决潜在的用户错误。然而,确保用户始终遵循这些说明仍然是一个挑战。
产品展望
按产品划分,市场分为尿液排卵检测套组、数位排卵检测套组和唾液排卵检测套组。在2022年的市场中,数位排卵检测套组获得了很大的收益占有率。数位排卵检测套组的出现预计将为新兴企业提供坚实的基础,并帮助他们在市场上占有一席之地。一些数位排卵检测套组具有内建记忆体或连接到智慧型手机应用程式的能力,允许用户随着时间的推移追踪他们的生育能力或深入了解月经週期。我可以。数位套件的这些功能预计将推动对这些创新套件的需求。此外,不断变化的医疗保健监管环境正在为新进入者获得这些机会创造有利条件。
配销通路展望
依配销通路,市场分为大卖场和超市、电子商务、药局和药局。 2022 年,电子商务部门在市场中占据了显着的收益占有率。该细分市场的成长归因于电子商务的普及,这使得零售电子商务网站的使用更加方便。网路存取的快速扩张和网路购物平台的日益普及进一步推动了这一趋势。此外,多样化的产品供应以及专业客户服务负责人的支援和资讯也有望对该领域的市场成长产生积极影响。
区域展望
从区域来看,我们对北美、欧洲、亚太地区和拉丁美洲/中东/非洲的市场进行了分析。 2022年,北美地区占据市场最大的收益占有率。这可能是由于蓝牙连接和智慧倒数功能等高级功能的出现,对排卵检测套组的需求增加。美国有大量工薪阶层人口,他们去看医疗保健提供者的时间往往有限,这有助于排卵检测套组销售的增加。这项因素进一步强化了区域市场。此外,製造商现在专注于开发新产品,这些新产品能够以更实惠的价格分布提供卓越的效果,同时确保输出的简单性和可靠性。
The Global Ovulation Testing Kits Market size is expected to reach $3.7 billion by 2030, rising at a market growth of 6.4% CAGR during the forecast period. In the year 2022, the market attained a volume of 5,06,912.7 thousand units, experiencing a growth of 4.8% (2019-2022).
Some advanced ovulation testing kits can connect to smartphones via Bluetooth or wireless. This connectivity enables real-time data transmission and the seamless integration of ovulation data into fertility apps. Therefore, the Digital Ovulation Test segment would acquire approximately 35% share of the market by 2030. Technological advancements have led to the development of smart algorithms that can predict ovulation more accurately based on a user's cycle history. These algorithms consider cycle length, LH surge patterns, and other relevant data points. High-tech ovulation testing kits can connect to Wi-Fi networks, allowing users to securely store and access their ovulation data. This element is particularly appealing to those who prioritize data privacy and security. Some ovulation testing kits offer customization options. Users can input their cycle data, such as cycle length, and receive more tailored predictions, making the kits suitable for a broader range of users. Some of the factors impacting the market are rising proportion of couples adopting delayed parenthood, rising incidence of fertility issues, and growing accuracy concerns regarding test results.
Delaying parenthood often goes hand in hand with increased fertility and reproductive health awareness. Many individuals and couples are well-informed about the potential challenges of conceiving as they age. This awareness has created a need for tools to help them understand and monitor their fertility more effectively. Delayed parenthood has led to a desire to make the most of the remaining fertile years. Ovulation testing kits offer a way to pinpoint the optimal time for conception. The rise in delayed parenthood has led to various educational initiatives and information sharing about fertility, family planning, and the use of ovulation testing kits. Additionally, Fertility issues, such as irregular menstrual cycles, endometriosis, polycystic ovary syndrome (PCOS), and male factor infertility, can make conception challenging. Couples facing these issues often use ovulation testing kits to help them track their fertile window more precisely. Ovulation testing kits are a valuable resource for couples struggling with fertility issues. Identifying the LH surge that precedes ovulation, these kits help couples time their intercourse effectively, increasing the likelihood of conception. The awareness of fertility challenges has led to a proactive approach to fertility management.
One of the most significant effects of the pandemic was a surge in demand for at-home medical products, including ovulation testing kits. With lockdowns and restrictions, many individuals sought to limit their visits to healthcare facilities, clinics, and pharmacies. This led to a higher preference for home-based healthcare solutions, including ovulation testing kits. As a result, the market for these kits experienced a notable boost in sales. On the other hand, for those actively trying to conceive, the heightened importance of maximizing their chances of success during the pandemic led to increased use of ovulation testing kits.
However, inaccurate results, such as false positives (indicating ovulation when it has not occurred) or false negatives (failing to detect an LH surge when it has occurred), can lead to confusion and frustration for users. These inaccuracies can affect family planning efforts and may contribute to consumer skepticism. The quality and consistency of ovulation testing kits can alter between and even within the same brand. Inconsistent results can undermine the reputation of these products and deter repeat purchases. Users may not always follow the instructions correctly, leading to inaccurate results. Manufacturers must address potential user errors by providing clear and detailed instructions. However, ensuring that users consistently follow these instructions remains a challenge.
Product Outlook
On the basis of product, the market is segmented into urine ovulation test, digital ovulation test, and saliva ovulation test. The digital ovulation test garnered a significant revenue share in the market in 2022. The emergence of digital ovulation test kits is anticipated to provide startups with a solid foundation that helps establish their presence in the market. Some digital ovulation tests have built-in memory or smartphone app connectivity, allowing users to track their fertility over time and gain insights into their menstrual cycles. Such features in digital kits are anticipated to increase the demand for these innovative kits. Furthermore, the evolving landscape of healthcare regulations creates favorable conditions for new entrants to gain access to these opportunities.
Distribution Channel Outlook
Based on distribution channel, the market is fragmented into hypermarkets & supermarkets, e-commerce, and pharmacies & drugstores. The e-commerce segment recorded a remarkable revenue share in the market in 2022. The segment's growth is attributed to the prevalence of COVID-19, which has made retail e-commerce websites more convenient to use. This trend is further attributed to the rapid expansion of Internet access and the increasing popularity of online shopping platforms. In addition, the availability of diverse product offerings and access to expert customer service personnel for support and information is expected to influence this segment's market growth positively.
Regional Outlook
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region generated the largest revenue share in the market. This can be attributed to the increasing demand for ovulation test kits due to the availability of advanced features like Bluetooth connectivity and smart countdown functions. The presence of a working-class population in the United States contributes to the increase in unit sales of ovulation test kits, as they often have limited time to visit a healthcare provider. This factor further enhances the regional market. Moreover, manufacturers are currently focusing on developing new products that can deliver superior results at a more affordable price point while ensuring their outputs' simplicity and reliability.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AccuQuik Testkits (AdvaCare Pharma), Fairhaven Health, LLC, Equinox Biotech Co., Ltd., Wondfo Biotech Co., Ltd, Pregmate, SPD Swiss Precision Diagnostics GmbH, Proov, Roman Health Ventures Inc. (Ro), Premom (Easy@Home Fertility), and Piramal Enterprises Limited.
Market Segments covered in the Report:
By Product (Volume, Thousand Units, USD Million, 2019-2030)
By Distribution Channel (Volume, Thousand Units, USD Million, 2019-2030)
By Geography (Volume, Thousand Units, USD Million, 2019-2030)
Companies Profiled
Unique Offerings from KBV Research